Two new diterpenes, named sibiriquinone A (1) and B (2), along with four known diterpenes have been isolated from the aerial part of Veronicastrum sibiricum. Their structures were elucidated by spectroscopy. The isolated compounds showed significant immunosuppressive activities.
Veronicastrum sibiricum (L.) PENNELL. (Scrophulariaceae), a medicinal plant growing in North China, has been used for treatment of rheumatism, dysentery, and arthritis. 1) Pharmacological research of extracts with V. sibiricum indicated that the CHCl 3 -extract had strong anti-inflammatory activity.
2) In our search for pharmacologically active compounds from crude drugs of plant origin, we have started work on the isolation of the active principles from the aerial part of V. sibiricum. This paper deals with the isolation and structure elucidation of two new and four known compounds from the petroleum ether-soluble fraction of V. sibiricum. An immunosuppressive bioassay was carried out with these noteworthy diterpenoids showing significant inhibitory effect on lymphocyte transformation.
The petroleum ether-soluble fraction of aerial part of V. sibiricum was separated by repeated silica gel column chromatography, Sephadex LH-20 and preparative HPLC to give compounds 1-6.
Sibiriquinone A (1) was obtained as red solid, and its HR-EI-MS spectrum showed a molecular ion peak at m/z 280.1485, indicating a molecular formula of C 19 H 20 O 2 . The IR spectrum of the compound showed carbonyl bond (1722 cm
Ϫ1
) and the UV spectrum revealed the presence of an aromatic ring (225, 275 nm In addition, signals of four methyl groups, one methine, one methylene and a quaternary carbon signals were also observed. Based on the above information, compound 1 was assumed to be an abietane-diterpene, with a p-quinone ring, similar to that of tritoquinone H which was reported in the previous paper. 3) In the HMBC spectrum of 1, the methine proton signal d . Therefore, the B-ring of 1 was an aromatic ring, and remaining double bond was located at C-1(2). Thus, the structure of sibirinone A (1) was elucidated as 11,14-dioxo-abieta-1,5(10),6,8,12-pentaene ( Fig. 1 ). Assignments of the 1 H-and 13 C-NMR spectral data were made on the basis of the 2D NMR spectra (see Experimental and Table 1 ).
Sibiriquinone B (2) 13 C-NMR spectral data was similar to those of 1, except for C-1, C-2 and C-10 (Table 1) . Compound 2 was assumed to be a 1,2-dihydro sibiriquinone A. In the HMBC spectrum, the proton signal at d H 3.17 (H-1) correlated with the signals at d C 19.0 (C-2), 37.8 (C-3), 149.6 (C-5), and 144.5 (C-10), and the methyl proton signal at d H 1.30 (H-18, 19) correlated with the signals at d C 37.8 (C-3) and 149.6 (C-5). Therefore, the structure of sibiriquinone B (2) was determined to be 11,14-dioxo-abieta-5(10),6,8,12-tetraene.
By comparing spectral data, the known compounds 3-6 were identified as tanshinone I (3), 4) dihydrotanshinone (4), 5) tanshinone IIA (5), 6) cryptotanshinone (6), 7) respectively. In a search for immunosuppressive substances, we examined the immuno-inhibitory effect of these diterpenes on lymphocyte transformation 8, 9) (Table 2) . The values of inhibition percent of compounds 1-6 revealed a significant distinction to the concanavalin A (Con A) control group (pϽ0.01, nϭ6), and showed inhibitory effect on lymphocyte transformation by comparing with a reference compound (dexamethasone). The immunosuppressive activity of these four known compounds has been determined for the first time.
Experimental
General Experimental Procedures NMR experiments were run on a Bruker AVANCE 300 instrument.
1 H-NMR, 300 MHz; 13 C-NMR, 75 MHz, both with tetramethylsilane as an internal standard. MS data were obtained on a MACKMS Auospec-utima ETOF instrument. Chromatography column, Silica-gel 60 (Qingdao Haiyang Chemical Co., Ltd.) and Sephadex LH-20 (Amersham Pharmacia Biotech); HPLC, JASCO Gulliver Series, PU-1580 (pump), RI1530 and UV1575 (detector). Column type, ODS (Hibar RT 250-25, LiChrosorb, RP-18); IR spectra were recorded on a 1710 Infrared Fourier Transform spectrometer (PERKIN-ELMER), UV spectra were obtained on a UVIKON XS recording spectrometer (BIO-TEK). Optical rotation was measured with a MC 241 digital polarimeter (PERKIN-ELMER).
Plant Material The aerial part of Veronicastrum sibiricum (L.) PENNELL. was collected in Aug. 2001 in North China, and identified by Prof. Liang-Xin Wang. A voucher specimen (D20010801) was deposited at the College of Pharmaceuticals and Biotechnology, Tianjin University, China.
Extraction and Isolation The dried aerial part (2.0 kg) of V. sibiricum was crushed and extracted 3 times with EtOH (95%, 15 l each) at 50°C for 6 h. The EtOH extracts were concd. in vacuo to give a residue (0.25 kg), which was partitioned between petroleum ether and H 2 O. The petroleum ether layer was concd. to give a residue (24.3 g), which was chromatographed on a silica-gel (800 g) column (80ϫ850 mm). The column was eluted with solvents of increasing polarity [petroleum ether-EtOAc (7 : 1, 5 : 1, 3 : 1, 1 : 1, 1 : 3), EtOAc, EtOAc-MeOH (19 : 1, 10 : 1)] to give 21 fractions (fr. 1-21). Combined fractions 11 and 12 (1.8 g) were chromatographed on a silica gel column (CHCl 3 -MeOH, 99 : 1, 95 : 5) to give six fractions (fr. 11.1-11.6). Fraction 11.3 (250 mg) was chromatographed on Sephadex LH-20 (MeOH) to give five fractions (fr. 11.3.1-11.3.5). Fraction 11.3.5 was separated by HPLC (ODS, CH 3 CN) to give 5 (27 mg). Fraction 9 (0.7 g) was chromatographed on silica gel (CHCl 3 -n-hexane, 9 : 1) to give seven fractions. (fr. 9.1-9.7). Fraction 9.6 was separated by HPLC (ODS, CH 3 CN) to give 1 (53 mg) and 2 (8 mg). Fraction 15 (1.8 g) was chromatographed on a silica-gel column (CHCl 3 ; CHCl 3 -MeOH, 98 : 2) to give four fractions (fr. 15.1-15.4) . Fraction 15.1 was crystallized using MeOH to give 3 (91 mg). Fraction 15.2 was dissolved with CH 3 CN and dissolved portion was separated by HPLC (ODS, CH 3 CN) to give 4 (7 mg) and 6 (17 mg).
Sibiriquinone A (1) Procedure of Bioassay The samples were prepared by dissolving the extract and compounds from V. sibiricum with dimethyl sulfoxide, followed by dilution of solutions into different concentrations with Hank's solution. Then, they were mixed with 1 ml of lymphocytes (5ϫ10 6 /ml) and incubated (37°C, 5% CO 2 ) for 72 h, concanavalin A (Con A) being used as a control group. The OD values of the samples were measured at 490 nm. OD dexamethasone ϭ63% (50 mg/ml).
